Artificial Muscles
Wow – muscles from nylon and conductive ink!! >>> http://newatlas.com/mit-robot-muscles-nylon/46611/?utm_source=Gizmag+Subscribers&utm_campaign=5d70b80327-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-5d70b80327-91677545
Wow – muscles from nylon and conductive ink!! >>> http://newatlas.com/mit-robot-muscles-nylon/46611/?utm_source=Gizmag+Subscribers&utm_campaign=5d70b80327-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-5d70b80327-91677545
Solanezumab ‘fails’ in Alzheimer’s at last Hate to say ‘we told you so’ all along! Julian, Bengt and I said so in our review article last year. There’s no substitute for the good old fashioned ordered process of clinical development – Learn first (Phase II) then Confirm (Phase III) Biogen (aducanumab) next? >>>> http://www.fiercebiotech.com/biotech/alzheimer-s-hopes-dashed-as-lilly-gives-up-amyloid-drug-solanezumab?utm_medium=nl&utm_source=internal&mrkid=938224&mkt_tok=eyJpIjoiWVdNMVltTXlPR1kyWlRjdyIsInQiOiI1NGFBR2dHK1BNXC9GRmkxdVVcL3I5K2I3dEtiVWkwbXppbTdPdmhpQkJlRFwvK1dvK0lmYmt4a25WZVRhbWJQd1NQQ3ZibkZJWlwvUzJzZ1Njck9hXC9qVGd3M0ptZFZmVVduZVBNRnFyVHhIR0xJPSJ9
My mate Tom’s approach to reducing screen failures in AD A complex statistical adaptive technique – REALLY! >> http://www.clinicalleader.com/doc/improving-screen-failure-and-recruitment-rates-in-alzheimer-s-disease-clinical-trials-0001?vm_tId=1965472&user=c4f6390a-527b-4ba6-97c0-6eff283b345d&utm_source=et_6212879&utm_medium=email&utm_campaign=CLNCL_11-21-2016&utm_term=c4f6390a-527b-4ba6-97c0-6eff283b345d&utm_content=Improving+Screen+Failure+And+Recruitment+Rates+In+Alzheimer%27s+Disease+Clinical+Trials
The Ergomed CRO services provider model seems to involve discounting the clinical management costs for shares in the development rights of the new compound Sounds like bit of an extreme and risky way of getting business to me >>> http://www.proactiveinvestors.co.uk/companies/news/124711/ergomed-s-hybrid-strategy-gives-it-plenty-of-ammo-124711.html
We worked on the Phase II premature ejaculation programme in 2007 What have they been doing for nearly 10 years! >>> http://www.pharmatimes.com/news/uk_launch_for_premature_ejaculation_spray_1176726?utm_source=PT+Daily+Newsletter&utm_medium=email&utm_campaign=pt+daily+news+alert
Just a few of mine (especially the patch) >>> https://www.mc10inc.com/our-products/biostamprc http://www.clouddx.com/index.html http://newatlas.com/aezon-aegle-arc-diagnostic-tricorder-xprize-health/33806/ The Aezon lot are just students and they don’t even have a Website 🙂 AND If you want to collect ePRO data as well >>> Axon
One way to make more sales Provide the diagnostic test to find new patients >>> http://www.fiercepharma.com/marketing/allergan-teams-up-ibs-d-platform-to-identify-potential-new-viberzi-patients?mkt_tok=eyJpIjoiTURJNU5tWmxOVGMxTWpjeiIsInQiOiJXN3VaVFhrdHdwWEFsTzkxRDg5MWJXSG5RTmJmY0E3YnJwSloyQU9zZjZkU2N3MFg3QndzYmdHZnRVSUxGYzZma1FZZjNCZ0p1QzhmUGhORnJSdXdqZmhCdStDOGhEMU5yd1BlbTU5QStaST0ifQ%3D%3D&mrkid=938224&utm_medium=nl&utm_source=internal
Hilarious! Scroll down to the bottom of the article (don’t read it) They just click on some of the characters they’ve dream’t up! Which do you reckon is the best/worst? >>> http://www.fiercepharma.com/special-report/top-10-animated-characters-pharma-marketing >>> The Mucinex Snot Monster is my favourite!!!
Great way to get ‘real time’ and probably more reliable ‘primary’ data in a problem condition without resorting to messy diary cards Excellent for motivating patients as well! >>> http://www.fiercepharma.com/marketing/takeda-looks-for-entyvio-boost-ibd-wearable-tech-program
Trust my old company to come up with this one 🙂 >>>> https://www.shire.com/en/newsroom/2016/october/yjizb2 I didn’t even know BED was an illness!